Adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B P Marcellin, TT Chang, SG Lim, MJ Tong, W Sievert, ML Shiffman, ... New England Journal of Medicine 348 (9), 808-816, 2003 | 2073 | 2003 |
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial HLA Janssen, M van Zonneveld, H Senturk, S Zeuzem, US Akarca, ... The Lancet 365 (9454), 123-129, 2005 | 1586 | 2005 |
Telbivudine versus lamivudine in patients with chronic hepatitis B CL Lai, E Gane, YF Liaw, CW Hsu, S Thongsawat, Y Wang, Y Chen, ... New England Journal of Medicine 357 (25), 2576-2588, 2007 | 1181 | 2007 |
Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis B Soto, A Sánchez-Quijano, L Rodrigo, JA del Olmo, ... Journal of hepatology 26 (1), 1-5, 1997 | 884 | 1997 |
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis RF Velázquez, M Rodrı́guez, CA Navascués, A Linares, R Pérez, ... Hepatology 37 (3), 520-527, 2003 | 563 | 2003 |
Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype HJ Flink, M Van Zonneveld, BE Hansen, RA De Man, SW Schalm, ... Official journal of the American College of Gastroenterology| ACG 101 (2 …, 2006 | 384 | 2006 |
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C J García-Samaniego, M Rodríguez, J Berenguer, R Rodríguez-Rosado, ... Am J Gastroenterol 96, 179-83, 2001 | 344 | 2001 |
Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis JG Abraldes, C Villanueva, C Aracil, J Turnes, M Hernandez-Guerra, ... Gastroenterology 150 (5), 1160-1170. e3, 2016 | 340 | 2016 |
Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B CE Westland, H Yang, WE Delaney IV, CS Gibbs, MD Miller, M Wulfsohn, ... Hepatology 38 (1), 96-103, 2003 | 235 | 2003 |
Propranolol Plus Placebo Versus Propranolol Plus Isosorbide–5–Mononitrate in the Prevention of A First Variceal Bleed: A Double–Blind Rct JC García-Pagán, R Morillas, R Bañares, A Albillos, C Villanueva, C Vila, ... Hepatology 37 (6), 1260-1266, 2003 | 223 | 2003 |
Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis YH Yeo, HJ Ho, HI Yang, TC Tseng, T Hosaka, HN Trinh, MS Kwak, ... Gastroenterology 156 (3), 635-646. e9, 2019 | 221 | 2019 |
Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 202 | 2022 |
Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups A Mancebo, ML González–Diéguez, V Cadahía, M Varela, R Pérez, ... Clinical gastroenterology and hepatology 11 (1), 95-101, 2013 | 201 | 2013 |
Prevalence and significance of hepatitis C viremia in chronic active hepatitis B J Crespo, JL Lozano, F de la Cruz, L Rodrigo, M Rodríguez, G San Miguel, ... American Journal of Gastroenterology 89 (8), 1147-1151, 1994 | 201 | 1994 |
Preemptive‐TIPS improves outcome in high‐risk variceal bleeding: an observational study V Hernández‐Gea, B Procopet, Á Giráldez, L Amitrano, C Villanueva, ... Hepatology 69 (1), 282-293, 2019 | 198 | 2019 |
Peginterferon alpha‐2b is safe and effective in HBeAg‐positive chronic hepatitis B patients with advanced fibrosis EHCJ Buster, BE Hansen, M Buti, J Delwaide, C Niederau, PP Michielsen, ... Hepatology 46 (2), 388-394, 2007 | 186 | 2007 |
"Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients? Am J Transplant 14 (3), 660-7, 2014 | 184 | 2014 |
Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive β-blockers JC García-Pagán, C Villanueva, MC Vila, A Albillos, J Genescà, ... Gastroenterology 121 (4), 908-914, 2001 | 182 | 2001 |
Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study G Sapisochin, CR De Lope, M Gastaca, JO De Urbina, R López-Andujar, ... Annals of surgery 259 (5), 944-952, 2014 | 180 | 2014 |
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS J Trebicka, W Gu, L Ibáñez-Samaniego, V Hernández-Gea, C Pitarch, ... Journal of hepatology 73 (5), 1082-1091, 2020 | 170 | 2020 |